SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Common Drug Review: A NICE start for Canada?
9 references·3 citing·44 second hop
The Common Drug Review: A NICE start for Canada? (2005)The Common Drug Review: A NICE start for …Priority Setting Toolkit: A Guide to the Use of Economics in Health Care Decision Making (2004)Priority Setting Toolkit: A G…National Institute for Clinical Excellence and its value judgments (2004)National Institute for Clinic…Cost effectiveness analysis in health care: contraindications (2002)Cost effectiveness analysis i…Wrong SIGN, NICE mess: is national guidance distorting allocation of resources? (2001)Wrong SIGN, NICE mess: is nat…NICE: faster access to modern treatments? Analysis of guidance on health technologies (2001)NICE: faster access to modern…Dancing with the porcupine: rules for governing the university-industry relationship. (2001)Dancing with the porcupine: r…A Dog’s Breakfast: (2001)A Dog’s Breakfast:The Pharmaceutical Industry — To Whom is It Accountable? (2000)The Pharmaceutical Industry —…Canadian Coordinating Office for Health Technology Assessment. (1992)Canadian Coordinating Office …Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare (2018)Prescription drug coverage in…A Synthesis of Drug Reimbursement Decision-Making Processes in Organisation for Economic Co-operation and Development Countries (2014)A Synthesis of Drug Reimburse…Pharmaceutical Pricing Policies in a Global Market (2008)Pharmaceutical Pricing Polici…Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Cost-effectiveness analysis. (1993)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Cost-Effectiveness of a Telephone-Delivered Intervention for Physical Activity and Diet (2009)Trying to estimate a monetary value for the QALY (2009)IMPLEMENTATION OF EUNETHTA CORE MODEL® IN LOMBARDIA: THE VTS FRAMEWORK (2014)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)EuroQol: the current state of play (1996)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)Delivering affordable cancer care in high-income countries (2011)The Existence of Publication Bias and Risk Factors for Its Occurrence (1990)Publication bias in clinical research (1991)Conflict of Interest Policies at Canadian Universities: Clarity and Content (2007)Supervisor–Student Relations: Examining the Spectrum of Conflicts of Interest in Bioscience Laboratories (2009)Standardization and Omics Science: Technical and Social Dimensions Are Inseparable and Demand Symmetrical Study (2010)THE Kept UNIVERSITY (2017)Equilibrium in Competitive Insurance Markets: An Essay on the Economics of Imperfect Information (1976)Measuring Agreement for Multinomial Data (1982)Analysis of Panel Data (2003)Who's the Fairest of Them All? Which Provincial Pharmacare Model Would Best Protect Canadians Against Catastrophic Drug Costs? (2004)When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions (2005)Cost-related prescription nonadherence in the united states and Canada: A system-level comparison using the 2007 international health policy survey in seven countries (2009)Capital-Market Imperfections and Investment (1997)The price of innovation: new estimates of drug development costs (2003)Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers (2010)Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective (2018)Managed competition for the poor or poorly managed competition? Lessons from the Colombian health reform experience (2001)Using economics to set pragmatic and ethical priorities (2006)Overcoming barriers to priority setting using interdisciplinary methods (2009)‘Real-world’ health care priority setting using explicit decision criteria: a systematic review of the literature (2015)Generic and Specific Measurement of Health-Related Quality of Life in a Clinical Trial of Respiratory Rehabilitation (1999)A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries (2004)Demythologizing the high costs of pharmaceutical research (2011)A Cost-Effectiveness Approach To Drug Subsidy And Pricing In Australia (2001)Comment on ???The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development??? (2005)Prices & availability of common medicines at six sites in India using a standard methodology. (2007)Dilemmas In Regulation Of The Market For Pharmaceuticals (2003)NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales (2003)Economic evaluation to inform health care decision-making: Promise, pitfalls and a proposal for an alternative path (2011)A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme (2004)Modelling in the economic evaluation of health care: selecting the appropriate approach (2004)The cost-effectiveness of screening for oral cancer in primary care (2006)
this work references cited by second hop

References

  • 2004National Institute for Clinical Excellence and its value judgments767 cited
  • 2001NICE: faster access to modern treatments? Analysis of guidance on health technologies299 cited
  • 1992Canadian Coordinating Office for Health Technology Assessment.293 cited
  • 2000The Pharmaceutical Industry — To Whom is It Accountable?164 cited
  • 2002Cost effectiveness analysis in health care: contraindications134 cited
  • 2004Priority Setting Toolkit: A Guide to the Use of Economics in Health Care Decision Making117 cited
  • 2001Wrong SIGN, NICE mess: is national guidance distorting allocation of resources?93 cited
  • 2001A Dog’s Breakfast:89 cited
  • 2001Dancing with the porcupine: rules for governing the university-industry relationship.88 cited

Cited by

  • 2008Pharmaceutical Pricing Policies in a Global Market72 cited
  • 2014A Synthesis of Drug Reimbursement Decision-Making Processes in Organisation for Economic Co-operation and Development Countries67 cited
  • 2018Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare63 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work